Comparing treatment strategies for heart failure: a real-world analysis of adding ARNI or SGLT2i to older GDMT

被引：0
|
作者：
Amornritvanich, P. [1 ]
Numthavaj, P. [1 ]
Anothaisintawee, T. [1 ]
Tansawet, A. [2 ]
Thakkinstian, A. [1 ]
机构：
[1] Mahidol Univ, Ramathibodi Hosp, Bangkok, Thailand
[2] Navamindradhiraj Univ, Fac Med Vajira Hosp, Dept Surg, Bangkok, Thailand
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.1221
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] SGLT2i treatment at the beginning of real time exposure in a HFrEF population
    Vintila, V.
    Ciocanel, A.
    Stamate, E.
    Vintila, A. M.
    Vinereanu, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 251 - 251
  • [32] Growing role of SGLT2i in heart failure: evidence from clinical trials
    Varadhan, Ajay
    Stephan, Katarina
    Gupta, Rahul
    Vyas, Apurva V.
    Ranchal, Purva
    Aronow, Wilbert S.
    Hawwa, Nael
    Lanier, Gregg M.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (02) : 147 - 159
  • [33] Benefits of SGLT2i for the Treatment of Heart Failure Irrespective of Diabetes Diagnosis: A State-of-the-Art Review
    Delgado, Elias
    Jodar, Esteban
    Mezquita-Raya, Pedro
    Moreno-Perez, Oscar
    DIABETES THERAPY, 2022, 13 (SUPPL 1) : 19 - 34
  • [34] Benefits of SGLT2i for the Treatment of Heart Failure Irrespective of Diabetes Diagnosis: A State-of-the-Art Review
    Elías Delgado
    Esteban Jódar
    Pedro Mezquita-Raya
    Óscar Moreno-Pérez
    Diabetes Therapy, 2022, 13 : 19 - 34
  • [35] Impact of SGLT2i on cardiovascular outcomes and heart failure in patients with type 2 diabetes
    Jose Rodriguez, Juan
    Ortega-Paz, Luis
    Brugaletta, Salvatore
    Sabate, Manel
    AIMS MEDICAL SCIENCE, 2018, 5 (01): : 67 - 79
  • [36] EFFICACY OF SGLT2I IN ACUTE DECOMPENSATED HEART FAILURE WITH TYPE 2 DIABETES MELLITUS
    Long Doan
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E304 - E304
  • [37] Efficacy and safety analysis of angiotensin receptor neprilysin inhibition(ARNI)in patients with heart failure: a real-world retrospective study
    Wang, Xiaobo
    Pu, Jun
    Wang, Guixia
    Xu, Hui
    Liu, Liming
    Li, Zhen
    Qin, Ruijie
    Zhao, Xuemei
    Li, Ming
    Hao, Zedong
    Hu, Houxiang
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [38] Efficacy and safety analysis of angiotensin receptor neprilysin inhibition(ARNI)in patients with heart failure: a real-world retrospective study
    Xiaobo Wang
    Jun Pu
    Guixia Wang
    Hui Xu
    Liming Liu
    Zhen Li
    Ruijie Qin
    Xuemei Zhao
    Ming Li
    Zedong Hao
    Houxiang Hu
    BMC Cardiovascular Disorders, 23
  • [39] Metformin and SGLT2i as First-line Combination Therapy in Type 2 Diabetes: A Real-world Study With a Focus on Ethnicity
    Anson, Matthew
    Zhao, Sizheng Steven
    Essa, Hani
    Austin, Philip
    Ibarburu, Gema Hernandez
    Lip, Gregory Y. H.
    Alam, Uazman
    CLINICAL THERAPEUTICS, 2023, 45 (12) : 1259 - 1265
  • [40] Relationship between initial eGFR DIP with proteinuria after SGLT2i treatment, in patients with IgA nephropathy. A real-world clinical study
    Xydakis, Dimitris
    Antonaki, Ergini
    Tzali, Eleni
    Papapanagiotou, Michalis
    Petra, Christina
    Kostakis, Kostantinos
    Vardaki, Eleftheria
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2146 - I2146
12345